PROCEPT BioRobotics Corporation (PRCT) Deep Dive Video
Summary
A clinically differentiated urology robotics disruptor re-rating from “hypergrowth” to “disciplined scale,” with HYDROS + Category I reimbursement setting up a utilization-and-margin driven path to profitability—if execution holds.